The National Pediatric Cancer Foundation is a nonprofit organization dedicated to funding research to eliminate childhood cancer. Their focus is to fund research to find less toxic, more targeted therapies by partnering with leading hospitals nationwide. What makes the NPCF different? A majority of cancer research focuses on adult treatments and is done within the walls of individual institutions. In contrast, they fund clinical trials and COLLABORATE with a network of cutting-edge hospitals across the nation to fast track less-toxic, more targeted treatments.
All to increase the survival rate of children battling cancer.

Childhood Cancer Facts:
1 in 285 children will be diagnosed with cancer
43 children per day or 15,780 children per year are expected to be diagnosed with cancer
More than 95% of childhood cancer survivors will have a significant health related issue by the time they are 45 years of age (2); these health related issues are side-effects of either the cancer or more commonly, the result of its treatment.
Cancer is the number one cause of death by disease among children
Since 1980, only three drugs, two used in the treatment of ALL, teniposide (1990)(6) and clofarabine (2004)(7), and Unituxin (dinutuximab), recently approved in March, 2015(7) for use in high risk neuroblastoma, have been approved in the first instance for use in children (and only four additional new drugs have been approved for use by both adults and children)
Since 1980, fewer than 10 drugs have been developed for use in children with cancer
The average cost of a stay in a hospital for a child with cancer is $40,000 per stay
Only 4% of federal government cancer research funding goes to children
Source: Coalition Against Childhood Cancer